Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients
Abstract There is conflicting evidence on the favorable effects of vitamin D supplementation on metabolic profile in Type 2 diabetes mellitus (T2DM) patients and this might be due to genetic variations in vitamin D receptors (VDRs). Thus, we studied the metabolic effects of a 12-month vitamin D supp...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e1419b590e743ef9b4a9852332ebf40 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1e1419b590e743ef9b4a9852332ebf40 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1e1419b590e743ef9b4a9852332ebf402021-12-02T12:32:12ZVitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients10.1038/s41598-017-08621-72045-2322https://doaj.org/article/1e1419b590e743ef9b4a9852332ebf402017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08621-7https://doaj.org/toc/2045-2322Abstract There is conflicting evidence on the favorable effects of vitamin D supplementation on metabolic profile in Type 2 diabetes mellitus (T2DM) patients and this might be due to genetic variations in vitamin D receptors (VDRs). Thus, we studied the metabolic effects of a 12-month vitamin D supplementation in T2DM patients according to VDR polymorphisms. A total of 204 T2DM subjects received 2000 IU vitamin D3 daily for 12 months. Serum 25(OH)D and metabolic profiles were measured at baseline and after 12 months. VDR polymorphisms (Taq-I, Bsm-I, Apa-I and Fok-I) were identified using TaqMan genotyping assays. Vitamin D supplementation significantly increased HOMA β-cell function (p = 0.003) as well as significantly decreased triglycerides, total and LDL-cholesterol (p < 0.001). The lowest increment in 25(OH)D levels was detected in patients with Fok-I CC genotypes (p < 0.0001). With vitamin D supplementation, Taq-I GG genotype carriers showed significant improvements in triglycerides, LDL- and total cholesterol, insulin, HbA1c and HOMA-IR (p < 0.005, 0.01, < 0.001, < 0.005, 0.03 and 0.01, respectively). Similarly, Bsm-I TT genotype carriers showed significant improvements in triglycerides (p = 0.01), insulin and HOMA-IR (p-values < 0.05). In conclusion, improvements in metabolic profile due to vitamin D supplementation is influenced by VDR polymorphisms, specifically for carriers of Taq-I GG and Bsm-I TT genotypes.Nasser M. Al-DaghriAbdul Khader MohammedOmar S. Al-AttasMohammed Ghouse Ahmed AnsariKaiser WaniSyed D. HussainShaun SabicoGyanendra TripathiMajed S. AlokailNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Nasser M. Al-Daghri Abdul Khader Mohammed Omar S. Al-Attas Mohammed Ghouse Ahmed Ansari Kaiser Wani Syed D. Hussain Shaun Sabico Gyanendra Tripathi Majed S. Alokail Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients |
description |
Abstract There is conflicting evidence on the favorable effects of vitamin D supplementation on metabolic profile in Type 2 diabetes mellitus (T2DM) patients and this might be due to genetic variations in vitamin D receptors (VDRs). Thus, we studied the metabolic effects of a 12-month vitamin D supplementation in T2DM patients according to VDR polymorphisms. A total of 204 T2DM subjects received 2000 IU vitamin D3 daily for 12 months. Serum 25(OH)D and metabolic profiles were measured at baseline and after 12 months. VDR polymorphisms (Taq-I, Bsm-I, Apa-I and Fok-I) were identified using TaqMan genotyping assays. Vitamin D supplementation significantly increased HOMA β-cell function (p = 0.003) as well as significantly decreased triglycerides, total and LDL-cholesterol (p < 0.001). The lowest increment in 25(OH)D levels was detected in patients with Fok-I CC genotypes (p < 0.0001). With vitamin D supplementation, Taq-I GG genotype carriers showed significant improvements in triglycerides, LDL- and total cholesterol, insulin, HbA1c and HOMA-IR (p < 0.005, 0.01, < 0.001, < 0.005, 0.03 and 0.01, respectively). Similarly, Bsm-I TT genotype carriers showed significant improvements in triglycerides (p = 0.01), insulin and HOMA-IR (p-values < 0.05). In conclusion, improvements in metabolic profile due to vitamin D supplementation is influenced by VDR polymorphisms, specifically for carriers of Taq-I GG and Bsm-I TT genotypes. |
format |
article |
author |
Nasser M. Al-Daghri Abdul Khader Mohammed Omar S. Al-Attas Mohammed Ghouse Ahmed Ansari Kaiser Wani Syed D. Hussain Shaun Sabico Gyanendra Tripathi Majed S. Alokail |
author_facet |
Nasser M. Al-Daghri Abdul Khader Mohammed Omar S. Al-Attas Mohammed Ghouse Ahmed Ansari Kaiser Wani Syed D. Hussain Shaun Sabico Gyanendra Tripathi Majed S. Alokail |
author_sort |
Nasser M. Al-Daghri |
title |
Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients |
title_short |
Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients |
title_full |
Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients |
title_fullStr |
Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients |
title_full_unstemmed |
Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients |
title_sort |
vitamin d receptor gene polymorphisms modify cardiometabolic response to vitamin d supplementation in t2dm patients |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/1e1419b590e743ef9b4a9852332ebf40 |
work_keys_str_mv |
AT nassermaldaghri vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT abdulkhadermohammed vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT omarsalattas vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT mohammedghouseahmedansari vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT kaiserwani vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT syeddhussain vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT shaunsabico vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT gyanendratripathi vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients AT majedsalokail vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients |
_version_ |
1718394145199882240 |